Vanguard Group Inc Kura Oncology, Inc. Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,818,898 shares of KURA stock, worth $39.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,818,898

Previous 4,203,687 14.64%

Holding current value

$39.9 Million

Previous $82.1 Million 48.9%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$8.51 - $19.21 $5.24 Million - $11.8 Million	615,211 Added 14.64%	4,818,898 $42 Million
Q3 2024 Nov 13, 2024	BUY	$18.57 - $23.23 $3.03 Million - $3.79 Million	163,231 Added 4.04%	4,203,687 $82.1 Million
Q2 2024 Aug 13, 2024	SELL	$17.53 - $22.98 $446,085 - $584,772	-25,447 Reduced 0.63%	4,040,456 $83.2 Million
Q1 2024 May 10, 2024	BUY	$13.42 - $23.53 $378,605 - $663,828	28,212 Added 0.7%	4,065,903 $86.7 Million
Q4 2023 Feb 14, 2024	BUY	$7.58 - $14.38 $858,381 - $1.63 Million	113,243 Added 2.89%	4,037,691 $58.1 Million
Q3 2023 Nov 14, 2023	BUY	$8.44 - $11.86 $2.32 Million - $3.26 Million	275,173 Added 7.54%	3,924,448 $35.8 Million
Q2 2023 Aug 14, 2023	BUY	$9.62 - $13.99 $1.6 Million - $2.32 Million	166,055 Added 4.77%	3,649,275 $38.6 Million
Q1 2023 May 15, 2023	BUY	$10.71 - $14.6 $835,926 - $1.14 Million	78,051 Added 2.29%	3,483,220 $42.6 Million
Q4 2022 Feb 10, 2023	BUY	$11.23 - $16.9 $1.29 Million - $1.94 Million	114,968 Added 3.49%	3,405,169 $42.3 Million
Q3 2022 Nov 14, 2022	SELL	$12.01 - $19.45 $529,220 - $857,064	-44,065 Reduced 1.32%	3,290,201 $44.9 Million
Q2 2022 Aug 12, 2022	BUY	$10.71 - $18.33 $41,983 - $71,853	3,920 Added 0.12%	3,334,266 $61.1 Million
Q1 2022 May 13, 2022	BUY	$11.78 - $16.98 $667,195 - $961,713	56,638 Added 1.73%	3,330,346 $53.6 Million
Q4 2021 Feb 14, 2022	BUY	$12.22 - $19.57 $112,949 - $180,885	9,243 Added 0.28%	3,273,708 $45.8 Million
Q3 2021 Nov 12, 2021	SELL	$15.42 - $21.72 $218,732 - $308,098	-14,185 Reduced 0.43%	3,264,465 $61.1 Million
Q2 2021 Aug 13, 2021	BUY	$20.85 - $29.88 $68.4 Million - $98 Million	3,278,650 New	3,278,650 $68.4 Million

Others Institutions Holding KURA

# of Institutions

192

Shares Held

77.5M

Call Options Held

103K

Put Options Held

106K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $554M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Kura Oncology, Inc. Transaction History